| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0004610> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0010356> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0019994> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0205721> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C0949671> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C1265292> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34416313_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Ascension St. John Hospital, Detroit, MI. Electronic address: ashish.bhargava@ascension.org.\', \'Ascension St. John Hospital, Detroit, MI.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bhargava_Ashish> <https://research.tib.eu/covid-19/entity/Fukushima_Elisa_Akagi> <https://research.tib.eu/covid-19/entity/Johnson_Leonard> <https://research.tib.eu/covid-19/entity/Riederer_Kathleen> <https://research.tib.eu/covid-19/entity/Saravolatz_Louis> <https://research.tib.eu/covid-19/entity/Sharma_Mamta>
?:doi	S0196-6553(21)00545-910.1016/j.ajic.2021.08.010
?:doi	<https://research.tib.eu/covid-19/entity/S0196-6553%2821%2900545-910.1016/j.ajic.2021.08.010>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	American journal of infection control
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34416313>
?:pmid	<https://research.tib.eu/covid-19/entity/34416313>
?:pmid	34416313
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.062
?:rankingScore_hIndex	93
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0004610_PROCESS_OF_C0242444> <https://research.tib.eu/covid-19/entity/C0004610_PROCESS_OF_C0870668>
?:title	High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34416313>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34416313>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all